
Marsha M. Tsay
Examiner (ID: 332, Phone: (571)272-2938 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1124 |
| Issued Applications | 471 |
| Pending Applications | 130 |
| Abandoned Applications | 543 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17038246
[patent_doc_number] => 20210255205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/255827
[patent_app_country] => US
[patent_app_date] => 2019-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/255827 | COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASE | Jun 26, 2019 | Abandoned |
Array
(
[id] => 15321265
[patent_doc_number] => 20200000962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => LOAD BEARING CROWDED COLLAGEN CONSTRUCTS
[patent_app_type] => utility
[patent_app_number] => 16/453717
[patent_app_country] => US
[patent_app_date] => 2019-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16453717
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/453717 | LOAD BEARING CROWDED COLLAGEN CONSTRUCTS | Jun 25, 2019 | Abandoned |
Array
(
[id] => 15035331
[patent_doc_number] => 20190328670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => Microparticles for Oral Delivery
[patent_app_type] => utility
[patent_app_number] => 16/448539
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16448539
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/448539 | Microparticles for Oral Delivery | Jun 20, 2019 | Abandoned |
Array
(
[id] => 17681178
[patent_doc_number] => 11365419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Host cell and method for producing target protein using same
[patent_app_type] => utility
[patent_app_number] => 16/441424
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16111
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 257
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16441424
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/441424 | Host cell and method for producing target protein using same | Jun 13, 2019 | Issued |
Array
(
[id] => 17037124
[patent_doc_number] => 20210254082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => Promoter for Yeast
[patent_app_type] => utility
[patent_app_number] => 15/734682
[patent_app_country] => US
[patent_app_date] => 2019-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734682
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734682 | Promoter for yeast | Jun 2, 2019 | Issued |
Array
(
[id] => 15254637
[patent_doc_number] => 20190376052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => GLUCANASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM
[patent_app_type] => utility
[patent_app_number] => 16/424391
[patent_app_country] => US
[patent_app_date] => 2019-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 118519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 1998
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16424391
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/424391 | GLUCANASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | May 27, 2019 | Abandoned |
Array
(
[id] => 16867683
[patent_doc_number] => 20210161150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM
[patent_app_type] => utility
[patent_app_number] => 17/057601
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -204
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057601
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057601 | METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM | May 23, 2019 | Abandoned |
Array
(
[id] => 14990097
[patent_doc_number] => 20190314006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => DEVICE AND METHOD FOR PREPARING AND ADMINISTERING ONE-COMPONENT FIBRIN SEALANT
[patent_app_type] => utility
[patent_app_number] => 16/412487
[patent_app_country] => US
[patent_app_date] => 2019-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16412487
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/412487 | Device and method for preparing and administering one-component fibrin sealant | May 14, 2019 | Issued |
Array
(
[id] => 16961562
[patent_doc_number] => 20210213061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => GENETICALLY ENGINEERED CELL AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/055470
[patent_app_country] => US
[patent_app_date] => 2019-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17492
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055470
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/055470 | Genetically engineered cell and application thereof | May 14, 2019 | Issued |
Array
(
[id] => 14778581
[patent_doc_number] => 20190264188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => RECOMBINANT VITAMIN K DEPENDENT PROTEINS WITH HIGH SIALIC ACID CONTENT AND METHODS OF PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 16/409385
[patent_app_country] => US
[patent_app_date] => 2019-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16409385
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/409385 | RECOMBINANT VITAMIN K DEPENDENT PROTEINS WITH HIGH SIALIC ACID CONTENT AND METHODS OF PREPARING SAME | May 9, 2019 | Abandoned |
Array
(
[id] => 15681803
[patent_doc_number] => 20200095565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => METHODS AND COMPOSITIONS FOR MODIFIED FACTOR IX PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/401987
[patent_app_country] => US
[patent_app_date] => 2019-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16401987
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/401987 | METHODS AND COMPOSITIONS FOR MODIFIED FACTOR IX PROTEINS | May 1, 2019 | Abandoned |
Array
(
[id] => 16376642
[patent_doc_number] => 20200325484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => Enhancing gene expression by linking self-amplifying transcription factor with viral 2A-like peptide
[patent_app_type] => utility
[patent_app_number] => 16/382210
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382210
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382210 | Enhancing gene expression by linking self-amplifying transcription factor with viral 2A-like peptide | Apr 11, 2019 | Abandoned |
Array
(
[id] => 16839780
[patent_doc_number] => 20210147792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => YEAST OVER-EXPRESSING PROTEIN PHOSPHATASES ASSOCIATED WITH THE HOG PATHWAY
[patent_app_type] => utility
[patent_app_number] => 17/046920
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046920
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/046920 | YEAST OVER-EXPRESSING PROTEIN PHOSPHATASES ASSOCIATED WITH THE HOG PATHWAY | Apr 10, 2019 | Abandoned |
Array
(
[id] => 14581903
[patent_doc_number] => 20190218560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => METHODS AND COMPOSITIONS FOR REGULATION OF TRANSGENE EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 16/374042
[patent_app_country] => US
[patent_app_date] => 2019-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16374042
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/374042 | Methods and compositions for regulation of transgene expression | Apr 2, 2019 | Issued |
Array
(
[id] => 14926491
[patent_doc_number] => 20190298883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => INSOLUBLE NATIVE COLLAGEN FIBERS AND THEIR USE IN CELL AGGREGATES AND TISSUE CONSTRUCTS
[patent_app_type] => utility
[patent_app_number] => 16/371781
[patent_app_country] => US
[patent_app_date] => 2019-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16371781
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/371781 | INSOLUBLE NATIVE COLLAGEN FIBERS AND THEIR USE IN CELL AGGREGATES AND TISSUE CONSTRUCTS | Mar 31, 2019 | Abandoned |
Array
(
[id] => 16576587
[patent_doc_number] => 20210010988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => SYSTEMS AND METHODS FOR CHARACTERIZING SURFACTANT PROTEIN D (SP-D) OLIGOMERS
[patent_app_type] => utility
[patent_app_number] => 17/041682
[patent_app_country] => US
[patent_app_date] => 2019-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10115
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041682
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/041682 | Systems and methods for characterizing surfactant protein D (SP-D) oligomers | Mar 26, 2019 | Issued |
Array
(
[id] => 16341809
[patent_doc_number] => 20200306459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => USE OF FILLER IN AMPUTATED EXTREMITIES TO SIMULATE SOFT TISSUE COVERAGE
[patent_app_type] => utility
[patent_app_number] => 16/363259
[patent_app_country] => US
[patent_app_date] => 2019-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16363259
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/363259 | USE OF FILLER IN AMPUTATED EXTREMITIES TO SIMULATE SOFT TISSUE COVERAGE | Mar 24, 2019 | Abandoned |
Array
(
[id] => 14960753
[patent_doc_number] => 20190307854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => ALLELIC VARIANTS OF HUMAN FACTOR VIII
[patent_app_type] => utility
[patent_app_number] => 16/361027
[patent_app_country] => US
[patent_app_date] => 2019-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16361027
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/361027 | Allelic variants of human factor VIII | Mar 20, 2019 | Issued |
Array
(
[id] => 14963581
[patent_doc_number] => 20190309269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => THERAPEUTIC CELL SYSTEMS AND METHODS FOR TREATING HYPERURICEMIA AND GOUT
[patent_app_type] => utility
[patent_app_number] => 16/359979
[patent_app_country] => US
[patent_app_date] => 2019-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72986
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16359979
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/359979 | THERAPEUTIC CELL SYSTEMS AND METHODS FOR TREATING HYPERURICEMIA AND GOUT | Mar 19, 2019 | Abandoned |
Array
(
[id] => 17436123
[patent_doc_number] => 11261437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-01
[patent_title] => Procoagulant compounds
[patent_app_type] => utility
[patent_app_number] => 16/357153
[patent_app_country] => US
[patent_app_date] => 2019-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 37
[patent_no_of_words] => 40258
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16357153
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/357153 | Procoagulant compounds | Mar 17, 2019 | Issued |